Person: Morten Herholdt

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Drug label change wipes £4bn off Glaxo value

OVER £4 billion was wiped off the value of GlaxoSmithKline (GSK) yesterday after authorities proposed changes to the way its best-selling asthma drug is labelled in the United States.

Tue, 22 Nov, 2005

Rival puts AstraZeneca under pressure

Pharmaceuticals giant AstraZeneca saw its share price fall 2% today after a rival applied to make a copycat version of its key ulcer treatment.

Tue, 18 Oct, 2005

No suprises in store from GlaxoSmithKline, say analysts

Analysts are expecting few surprises when GlaxoSmithKline reveals its first quarter results tomorrow.

Mon, 23 Apr, 2001